Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
4.0
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.17
1.88
NAV
₹347.67
₹532.86
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1143.58 Cr
₹4323.29 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
10.25%
10.34%
3 Year
25.71%
24.62%
5 Year
13.79%
15.30%
Equity
95.25%
97.38%
Cash
4.74%
2.55%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.49% |
Ajanta Pharma Ltd. | 5.84% |
Lupin Ltd. | 4.23% |
Apollo Hospitals Enterprise Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.45% |
Glenmark Pharmaceuticals Ltd. | 3.35% |
Dr. Reddy's Laboratories Ltd. | 3.35% |
Gland Pharma Ltd. | 3.30% |
Fortis Healthcare Ltd. | 3.23% |
Alkem Laboratories Ltd. | 3.21% |
Sun Pharmaceutical Industries Ltd. | 11.71% |
Divi's Laboratories Ltd. | 6.77% |
Acutaas Chemicals Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.30% |
Max Healthcare Institute Ltd. | 5.17% |
Aster DM Healthcare Ltd. | 3.89% |
Lupin Ltd. | 3.84% |
Torrent Pharmaceuticals Ltd. | 3.48% |
Anthem Biosciences Ltd. | 3.45% |
Aether Industries Ltd. | 3.35% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999
